REG - Itaconix PLC - Appointment of Non-Executive Director

ItaconixAnnouncement

09/02/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240209:nRSI5627Ca&default-theme=true

RNS Number : 5627C  Itaconix PLC  09 February 2024

Itaconix plc

("Itaconix" or the "Company")

Appointment of Non-Executive Director

Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in sustainable
plant-based polymers used to decarbonise everyday consumer products, is
pleased to announce the appointment of Jonathan Brooks to the Board as an
independent Non-Executive Director.

Jonathan is recently retired from the European law firm Fieldfisher LLP where
he was a Partner in its highly regarded Equity Capital Markets practice. Prior
to joining Fieldfisher, he was a Partner and Head of the Capital Markets Group
at Maclay Murray & Spens LLP, having qualified as a solicitor and
subsequently becoming a Partner at Boodle Hatfield LLP.

With over 35 years of experience, Jonathan has acted for clients in a diverse
range of industries, including technology, materials, healthcare, natural
resources, renewable energy, and financial services. His experience extends
across key corporate growth activities, serving as a valued advisor in
numerous IPOs, fundraisings, and venture capital investments. He has managed
transactions and advised on legal, regulatory, corporate governance and
sustainability matters for a range of high-growth companies in the global
equity capital markets.

The appointment of Jonathan as a Non-Executive Director further strengthens
Itaconix's leadership team, bringing valuable London Stock Exchange and
international equity capital markets experience to further build the Company's
foundation for continued growth.

John R. Shaw, CEO of Itaconix, commented:  

"It is a pleasure to welcome Jonathan to our Board. Our CFO Laura Denner and I
have worked closely with Jonathan as our trusted counsel and advisor on many
critical advances in Itaconix's development and growth. We are excited to
embed his knowledge and understanding of fast-growing companies and equity
capital markets into our leadership, our governance, and our plans for the
future. We look forward to his valuable contributions as we continue to
innovate, and execute on our next stage of growth."

Regulatory disclosures

Full name: Jonathan Paul Brooks

Age: 60

Historic directorships and partnerships in previous 5 years:

 Company name      Position  Date ceased
 Fieldfisher LLP   Partner   30 June 2023
 FFW 1001 Limited  Director  2 February 2021

There is no further information to be disclosed in relation to the director
appointment pursuant to Rule 17 and Schedule 2, paragraph (g) of the AIM
Rules.

- Ends -

 

 Itaconix plc                                                                        +1 603 775-4400
 John R. Shaw / Laura Denner
 Belvedere Communications                                                     +44 (0)20 7653 8702
 John West / Llew Angus
 Canaccord Genuity - Nominated Adviser and Sole Broker  +44 (0) 20 7523 8000
 Adam James / Harry Pardoe

About Itaconix 

Itaconix uses its proprietary plant-based polymer technology platform to
produce and sell specialty ingredients that improve the safety, performance,
and sustainability of consumer products.  The Company's current ingredients
are enabling and leading new generations of products in cleaning, hygiene, and
beauty.

www.itaconix.com (http://www.itaconix.com/)  

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAEANAPEDALEFA